首页> 外文学位 >MHC class II polymorphism and central tolerance in autoimmune diabetes.
【24h】

MHC class II polymorphism and central tolerance in autoimmune diabetes.

机译:MHC II类多态性和自身免疫性糖尿病的中枢耐受性。

获取原文
获取原文并翻译 | 示例

摘要

Insulin-dependent diabetes mellitus is a complex disease characterized by the destruction of the pancreatic beta cells which produce insulin. A strong genetic link exist between autoimmunity and MHC class II polymorphism where different alleles infer either susceptibility or resistance from disease. The NOD mouse spontaneously develops IDDM and therefore provides an appropriate genetic background with which to study this disease. Previously it has been shown that T cells bearing an I-Ag7-restricted, beta cell reactive, highly diabetogenic T cell receptor (4.1-TCR) underwent negative selection when non-NOD MHC class II molecules were expressed in the 4.1-NOD background. Here it is shown that when 4.1-thymocytes interact with I-Ad, I-Ag7PD, or I-Eαk MHC class II molecules (expressed as transgenes) they undergo different levels of tolerance. Therefore, anti-diabetogenic MHC class II molecules may provide protection from disease by having a tolerogenic affect on highly pathogenic, 4.1-like CD4+ T cells.
机译:胰岛素依赖性糖尿病是一种复杂的疾病,其特征是破坏了产生胰岛素的胰岛β细胞。自身免疫与MHC II类多态性之间存在很强的遗传联系,其中不同的等位基因可推断出对疾病的敏感性或耐药性。 NOD小鼠自发形成IDDM,因此提供了研究该疾病的适当遗传背景。以前已经显示,当在非NOD MHC II类分子中表达IA g7 限制,β细胞反应性,高糖尿病性T细胞受体(4.1-TCR)时,T细胞会进行阴性选择。 4.1点背景。此处显示当4.1胸腺细胞与IA d ,IA g7PD 或I-Eα k MHC II类分子相互作用时(表示为转基因),它们会经历不同程度的耐受性。因此,抗糖尿病的MHC II类分子通过对高致病性的4.1样CD4 + T细胞产生致耐受作用,可以提供抗疾病的保护。

著录项

  • 作者

    Thiessen, Shari Joy.;

  • 作者单位

    University of Calgary (Canada).;

  • 授予单位 University of Calgary (Canada).;
  • 学科 Health Sciences Immunology.
  • 学位 M.Sc.
  • 年度 2001
  • 页码 71 p.
  • 总页数 71
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 预防医学、卫生学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号